모바일 의료 앱 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The global mobile medical apps market size is expected to reach USD 148.69 Billion in 2034 from USD 15.50 Billion in 2025, growing at a CAGR of 28.56% during 2026-2034.This market is growing as smartphones become increasingly integrated into healthcare management, wellness monitoring, communication, and patient-support activities. Mobile medical applications can provide medication reminders, appointment management, symptom tracking, health information, remote monitoring, and selected clinical support functions. Healthcare providers are also using mobile applications to communicate with patients and support digital care pathways. Increasing smartphone penetration and broader acceptance of digital healthcare services are creating a strong foundation for continued application development.

The expansion of telemedicine and remote patient management is encouraging demand for mobile applications that connect patients with healthcare professionals and monitoring systems. Wearable-device integration can allow applications to collect activity, heart-rate, sleep, and other health-related information where appropriate. Hospitals and healthcare organizations are also developing patient-facing applications for scheduling, records access, communication, and treatment support. Meanwhile, artificial intelligence is being incorporated into selected applications for personalization, information processing, and decision-support functions.

Future prospects depend on regulatory development, clinical validation, data security, and integration with healthcare information systems. Applications with strong interoperability can connect patients, clinicians, pharmacies, laboratories, and connected devices more effectively. Artificial intelligence and remote monitoring can broaden functionality, although appropriate clinical oversight remains important for medical applications. Developers are expected to focus on privacy, cybersecurity, accessibility, and evidence-based features. As healthcare delivery becomes increasingly digital, mobile applications can play a larger role in patient engagement and selected areas of ongoing care management.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By App Type / Function

• Telemedicine & Virtual Care Apps
• Remote Patient Monitoring (RPM) Apps
• Diagnostic & Clinical Decision Support Apps
• Medication Management & Adherence Apps
• Chronic Disease Management Apps (diabetes, cardiovascular, respiratory)
• Mental Health & Behavioral Health Apps
• Wellness & Lifestyle Apps (fitness, nutrition, sleep)
• Clinical Trial & Research Apps
• Administrative / Practice Management Apps

By Deployment Model

• On-premises (enterprise deployments)
• Cloud-based / SaaS

By End-user

• Hospitals & Health Systems
• Ambulatory Care & Clinics
• Patients / Consumers
• Payers & Health Insurance Companies
• Employers & Corporate Wellness Programs
• Pharmaceutical & MedTech Companies
• Research Institutions

By Therapeutic Area

• Cardiovascular
• Diabetes & Endocrinology
• Respiratory (COPD, asthma)
• Oncology
• Mental Health
• Neurology
• Musculoskeletal & Orthopaedics
• Others

By Regulatory Status

• Wellness / Unregulated Apps
• Medical Device / Regulated Apps (cleared/approved)

COMPANIES PROFILED

• Apple Inc., Google LLC, Epic Systems Corporation, Philips Healthcare, Medtronic plc, Abbott Laboratories, Teladoc Health, Inc. / Livongo, Propeller Health, Pear Therapeutics Inc., Welldoc Inc., Samsung Electronics Co. Ltd., Qualcomm Technologies Inc., AT&T Inc., Orange S.A., Veradigm Inc.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL MOBILE MEDICAL APPS MARKET: BY APP TYPE / FUNCTION 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast App Type / Function
• 4.2. Telemedicine & Virtual Care Apps Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Remote Patient Monitoring (RPM) Apps Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Diagnostic & Clinical Decision Support Apps Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Medication Management & Adherence Apps Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Chronic Disease Management Apps (diabetes, cardiovascular, respiratory) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.7. Mental Health & Behavioral Health Apps Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.8. Wellness & Lifestyle Apps (fitness, nutrition, sleep) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.9. Clinical Trial & Research Apps Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.10. Administrative / Practice Management Apps Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL MOBILE MEDICAL APPS MARKET: BY DEPLOYMENT MODEL 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Deployment Model
• 5.2. On-premises (enterprise deployments) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Cloud-based / SaaS Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL MOBILE MEDICAL APPS MARKET: BY END-USER 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End-user
• 6.2. Hospitals & Health Systems Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Ambulatory Care & Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Patients / Consumers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Payers & Health Insurance Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.6. Employers & Corporate Wellness Programs Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.7. Pharmaceutical & MedTech Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.8. Research Institutions Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL MOBILE MEDICAL APPS MARKET: BY THERAPEUTIC AREA 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast Therapeutic Area
• 7.2. Cardiovascular Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Diabetes & Endocrinology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Respiratory (COPD, asthma) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.5. Oncology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.6. Mental Health Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.7. Neurology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.8. Musculoskeletal & Orthopaedics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.9. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL MOBILE MEDICAL APPS MARKET: BY REGULATORY STATUS 2022-2034 (USD MN)

• 8.1. Market Analysis, Insights and Forecast Regulatory Status
• 8.2. Wellness / Unregulated Apps Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.3. Medical Device / Regulated Apps (cleared/approved) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 9. GLOBAL MOBILE MEDICAL APPS MARKET: BY REGION 2022-2034 (USD MN)

• 9.1. Regional Outlook
• 9.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.2.1 By App Type / Function
  • 9.2.2 By Deployment Model
  • 9.2.3 By End-user
  • 9.2.4 By Therapeutic Area
  • 9.2.5 By Regulatory Status
  • 9.2.6 United States
  • 9.2.7 Canada
  • 9.2.8 Mexico
• 9.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.3.1 By App Type / Function
  • 9.3.2 By Deployment Model
  • 9.3.3 By End-user
  • 9.3.4 By Therapeutic Area
  • 9.3.5 By Regulatory Status
  • 9.3.6 United Kingdom
  • 9.3.7 France
  • 9.3.8 Germany
  • 9.3.9 Italy
  • 9.3.10 Spain
  • 9.3.11 Russia
  • 9.3.12 Rest Of Europe
• 9.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.4.1 By App Type / Function
  • 9.4.2 By Deployment Model
  • 9.4.3 By End-user
  • 9.4.4 By Therapeutic Area
  • 9.4.5 By Regulatory Status
  • 9.4.6 China
  • 9.4.7 Japan
  • 9.4.8 South Korea
  • 9.4.9 India
  • 9.4.10 Australia
  • 9.4.11 South East Asia
  • 9.4.12 Rest Of Asia Pacific
• 9.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.5.1 By App Type / Function
  • 9.5.2 By Deployment Model
  • 9.5.3 By End-user
  • 9.5.4 By Therapeutic Area
  • 9.5.5 By Regulatory Status
  • 9.5.6 Brazil
  • 9.5.7 Argentina
  • 9.5.8 Peru
  • 9.5.9 Chile
  • 9.5.10 Rest of Latin America
• 9.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.6.1 By App Type / Function
  • 9.6.2 By Deployment Model
  • 9.6.3 By End-user
  • 9.6.4 By Therapeutic Area
  • 9.6.5 By Regulatory Status
  • 9.6.6 Saudi Arabia
  • 9.6.7 UAE
  • 9.6.8 Israel
  • 9.6.9 South Africa
  • 9.6.10 Rest of the Middle East And Africa

Chapter 10. COMPETITIVE LANDSCAPE

• 10.1. Recent Developments
• 10.2. Company Categorization
• 10.3. Supply Chain & Channel Partners (based on availability)
• 10.4. Market Share & Positioning Analysis (based on availability)
• 10.5. Vendor Landscape (based on availability)
• 10.6. Strategy Mapping

Chapter 11. COMPANY PROFILES OF GLOBAL MOBILE MEDICAL APPS INDUSTRY

• 11.1. Top Companies Market Share Analysis
• 11.2. Company Profiles
  • 11.2.1 Apple Inc
  • 11.2.2 Google LLC
  • 11.2.3 Epic Systems Corporation
  • 11.2.4 Philips Healthcare
  • 11.2.5 Medtronic Plc
  • 11.2.6 Abbott Laboratories
  • 11.2.7 Teladoc Health
  • 11.2.8 Inc. / Livongo
  • 11.2.9 Propeller Health
  • 11.2.10 Pear Therapeutics Inc
  • 11.2.11 Welldoc Inc
  • 11.2.12 Samsung Electronics Co. Ltd
  • 11.2.13 Qualcomm Technologies Inc
  • 11.2.14 AT&T Inc
  • 11.2.15 Orange S.A
  • 11.2.16 Veradigm Inc